Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.47% |
| 2 | Technology | 8.38% |
| 3 | Healthcare | 7.46% |
| 4 | Consumer Discretionary | 5.14% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4251
AST SpaceMobile
ASTS
$17.4B
| $689K | ﹤0.01% |
146,562
-11,165
| -7% | -$57.9K |
|
4252
CALL
Penumbra
PEN
$12.7B
| $688K | ﹤0.01% |
2,000
-29,400
| -94% | -$9.03M |
|
4253
Vera Bradley
VRA
$94.1M
| $687K | ﹤0.01% |
107,552
-273,363
| -72% | -$1.54M |
|
4254
BlueLinx
BXC
$624M
| $686K | ﹤0.01% |
7,311
+2,985
| +69% | +$239K |
|
4255
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.78B
| $686K | ﹤0.01% |
5,321
-22,737
| -81% | -$2.85M |
|
4256
CALL
Louisiana-Pacific
LPX
$4.98B
| $682K | ﹤0.01% |
+9,100
| New | +$563K |
|
4257
PUT
BioNTech
BNTX
$25.6B
| $680K | ﹤0.01% |
+6,300
| New | +$709K |
|
4258
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.5B
| $679K | ﹤0.01% |
23,069
-131,449
| -85% | -$3.88M |
|
4259
Graham Corp
GHM
$1.01B
| $678K | ﹤0.01% |
51,076
-12,083
| -19% | -$152K |
|
|
CTRA
4260
PUT
DELISTED
Coterra Energy
CTRA
| $678K | ﹤0.01% |
+26,800
| New | +$666K |
|
4261
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.7B
| $678K | ﹤0.01% |
13,400
+5,400
| +68% | +$274K |
|
|
JWN
4262
CALL
DELISTED
Nordstrom
JWN
| $678K | ﹤0.01% |
33,100
-26,000
| -44% | -$437K |
|
4263
Cytosorbents Corp
CTSO
$21.1M
| $676K | ﹤0.01% |
188,389
-10,158
| -5% | -$32.1K |
|
4264
Euroseas
ESEA
$541M
| $675K | ﹤0.01% |
+38,274
| New | +$626K |
|
4265
LCI Industries
LCII
$2.5B
| $675K | ﹤0.01% |
5,338
-5,516
| -51% | -$632K |
|
4266
CALL
Planet Fitness
PLNT
$4.03B
| $674K | ﹤0.01% |
+10,000
| New | +$717K |
|
4267
CALL
Agilon Health
AGL
$1.55B
| $673K | ﹤0.01% |
1,552
-3,432
| -69% | -$1.93M |
|
4268
Vanguard Russell 1000 Growth ETF
VONG
$45.1B
| $673K | ﹤0.01% |
+9,506
| New | +$622K |
|
4269
CALL
Adaptive Biotechnologies
ADPT
$4.02B
| $671K | ﹤0.01% |
100,000
-70,000
| -41% | -$520K |
|
|
EQC
4270
DELISTED
Equity Commonwealth
EQC
| $670K | ﹤0.01% |
33,091
-222,359
| -87% | -$4.6M |
|
|
STER
4271
DELISTED
Sterling Check Corp. Common Stock
STER
| $670K | ﹤0.01% |
+54,637
| New | +$655K |
|
|
ADAM
4272
Adamas Trust
ADAM
$881M
| $668K | ﹤0.01% |
67,384
+47,727
| +243% | +$474K |
|
4273
Waterstone Financial
WSBF
$379M
| $664K | ﹤0.01% |
45,836
+30,546
| +200% | +$436K |
|
|
TELL
4274
DELISTED
Tellurian Inc.
TELL
| $664K | ﹤0.01% |
470,936
-975,844
| -67% | -$1.31M |
|
4275
Lyell Immunopharma
LYEL
$356M
| $664K | ﹤0.01% |
10,434
-6,864
| -40% | -$380K |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander's Q2 2023 filing shows 870 new, 2,213 increased, 2,337 reduced and 1,192 closed positions. Its largest new stake was ResMed: 632,015 shares worth $138M. The largest sale was Tesla, an estimated $491M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.